David R Kronenthal

USPTO Granted Patents = 39 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 140(Granted Patents)

Company Filing History:

20 out of 1,624

E. R. Squibb Sons, Inc.

patents

18 out of 3,681

Bristol-myers Squibb Compnay

patents

1 out of 832,680

Other

patents

Years Active: 1985-2016

Loading Chart...

39 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9249171 - Sulfilimine and sulphoxide methods for producing festinavir (2016-02-02),

2. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2011-06-28),

3. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2009-10-13),

4. 7074921 - Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds (2006-07-11),

5. 7034152 - Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2006-04-25),

6. 6486315 - Recrystallization processes (2002-11-26),

7. 6444810 - Deprotection processes (2002-09-03),

8. 6399793 - Process for the preparation of &agr;' chloroketones (2002-06-04),

9. 6340752 - Deprotection and recrystallization processes (2002-01-22),

10. 6335324 - Beta lactam compounds and their use as inhibitors of tryptase (2002-01-01),

11. 6329542 - Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes (2001-12-11),

12. 6248882 - Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes (2001-06-19),

13. 6166227 - Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via (2000-12-26),

14. 5629429 - Process for preparing 4-arylamino-benzopyran and related compounds (1997-05-13),

15. 5616775 - Process for preparing homocystein analogs useful as intermediates for (1997-04-01),

Title: Innovative Contributions of David R. Kronenthal

Introduction

David R. Kronenthal, based in Yardley, PA, is a prolific inventor known for his significant contributions to the field of pharmaceutical chemistry. With 39 patents to his name, Kronenthal has established himself as an influential figure in the development of novel compounds and processes.

Latest Patents

Among his most recent patents, Kronenthal developed methods for producing festinavir, utilizing sulfilimine and sulfoxide processes for the compound of Formula I. Another noteworthy patent involves a process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives, which introduces novel intermediates and salt forms produced in the process. These innovations reflect Kronenthal's expertise in synthesizing complex chemical structures.

Career Highlights

Throughout his career, David R. Kronenthal has made impactful strides while working for notable companies in the pharmaceutical sector, including E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His work has contributed to advances in drug development, benefitting both the industry and society.

Collaborations

Kronenthal has collaborated with talented peers including John K. Thottathil and Mark D. Schwinden. These partnerships have enhanced his innovative endeavors, allowing for the exchange of ideas and expertise in pursuit of groundbreaking developments.

Conclusion

David R. Kronenthal's dedication to innovation and his impressive portfolio of patents underscore his role as a leader in pharmaceutical research. His contributions not only demonstrate individual brilliance but also reflect the importance of collaboration in the pursuit of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.